Cargando…
Transferability of real-world data across borders for regulatory and health technology assessment decision-making
Recently, there has been increased consideration of real-world data (RWD) and real-world evidence (RWE) in regulatory and health technology assessment (HTA) decision-making. Due to challenges in identifying high-quality and relevant RWD sources, researchers and regulatory/HTA bodies may turn to RWD...
Autores principales: | Jaksa, Ashley, Arena, Patrick J., Chan, Kelvin K. W., Ben-Joseph, Rami H., Jónsson, Páll, Campbell, Ulka B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709526/ https://www.ncbi.nlm.nih.gov/pubmed/36465931 http://dx.doi.org/10.3389/fmed.2022.1073678 |
Ejemplares similares
-
A Structured Preapproval and Postapproval Comparative Study Design Framework to Generate Valid and Transparent Real‐World Evidence for Regulatory Decisions
por: Gatto, Nicolle M., et al.
Publicado: (2019) -
Availability of comparative real-world evidence research in Medicare patients: implications for Centers for Medicare and Medicaid Services drug price negotiations
por: Jaksa, Ashley, et al.
Publicado: (2023) -
Real-world evidence for regulatory decision-making: updated guidance from around the world
por: Burns, Leah, et al.
Publicado: (2023) -
The real-world impact of National Institute for Health and Care Excellence's real-world evidence framework
por: Duffield, Stephen, et al.
Publicado: (2023) -
Real‐World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe
por: Cave, Alison, et al.
Publicado: (2019)